Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
AVAH vs MMS vs TDOC vs CACI vs SAIC
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Medical - Healthcare Information Services
Information Technology Services
Information Technology Services
AVAH vs MMS vs TDOC vs CACI vs SAIC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Specialty Business Services | Medical - Healthcare Information Services | Information Technology Services | Information Technology Services |
| Market Cap | $1.42B | $3.51B | $1.31B | $10.62B | $4.23B |
| Revenue (TTM) | $2.43B | $5.32B | $2.51B | $9.16B | $7.26B |
| Net Income (TTM) | $225M | $373M | $-171M | $537M | $358M |
| Gross Margin | 33.1% | 24.6% | 65.6% | 14.9% | 12.0% |
| Operating Margin | 10.9% | 10.8% | -7.6% | 9.3% | 7.1% |
| Forward P/E | 11.6x | 7.7x | — | 17.1x | 9.3x |
| Total Debt | $1.34B | $1.44B | $1.04B | $3.34B | $217M |
| Cash & Equiv. | $193M | $260M | $781M | $106M | $182M |
AVAH vs MMS vs TDOC vs CACI vs SAIC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Aveanna Healthcare … (AVAH) | 100 | 57.7 | -42.3% |
| Maximus, Inc. (MMS) | 100 | 70.1 | -29.9% |
| Teladoc Health, Inc. (TDOC) | 100 | 4.2 | -95.8% |
| CACI International … (CACI) | 100 | 188.7 | +88.7% |
| Science Application… (SAIC) | 100 | 105.0 | +5.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVAH vs MMS vs TDOC vs CACI vs SAIC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVAH carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 20.2%, EPS growth 19.5%, 3Y rev CAGR 10.8%
- 20.2% revenue growth vs SAIC's -2.9%
- 9.2% margin vs TDOC's -6.8%
- +22.5% vs SAIC's -21.7%
MMS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 2 yrs, beta 0.63, yield 1.8%
- Beta 0.63, yield 1.8%, current ratio 1.64x
- Lower P/E (7.7x vs 17.1x), PEG 0.76 vs 1.41
- 1.8% yield, 2-year raise streak, vs SAIC's 1.6%, (3 stocks pay no dividend)
TDOC lags the leaders in this set but could rank higher in a more targeted comparison.
CACI is the clearest fit if your priority is long-term compounding.
- 406.9% 10Y total return vs SAIC's 104.0%
SAIC ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.27, Low D/E 14.5%, current ratio 1.20x
- PEG 0.56 vs CACI's 1.41
- Beta 0.27 vs TDOC's 1.89, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.2% revenue growth vs SAIC's -2.9% | |
| Value | Lower P/E (7.7x vs 17.1x), PEG 0.76 vs 1.41 | |
| Quality / Margins | 9.2% margin vs TDOC's -6.8% | |
| Stability / Safety | Beta 0.27 vs TDOC's 1.89, lower leverage | |
| Dividends | 1.8% yield, 2-year raise streak, vs SAIC's 1.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +22.5% vs SAIC's -21.7% | |
| Efficiency (ROA) | 12.4% ROA vs TDOC's -5.9%, ROIC 15.1% vs -11.5% |
AVAH vs MMS vs TDOC vs CACI vs SAIC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVAH vs MMS vs TDOC vs CACI vs SAIC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVAH leads in 3 of 6 categories
TDOC leads 1 • SAIC leads 1 • MMS leads 1 • CACI leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVAH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CACI is the larger business by revenue, generating $9.2B annually — 3.8x AVAH's $2.4B. AVAH is the more profitable business, keeping 9.2% of every revenue dollar as net income compared to TDOC's -6.8%. On growth, AVAH holds the edge at +27.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.4B | $5.3B | $2.5B | $9.2B | $7.3B |
| EBITDAEarnings before interest/tax | $289M | $645M | $42M | $1.1B | $666M |
| Net IncomeAfter-tax profit | $225M | $373M | -$171M | $537M | $358M |
| Free Cash FlowCash after capex | $126M | $372M | $251M | $470M | $609M |
| Gross MarginGross profit ÷ Revenue | +33.1% | +24.6% | +65.6% | +14.9% | +12.0% |
| Operating MarginEBIT ÷ Revenue | +10.9% | +10.8% | -7.6% | +9.3% | +7.1% |
| Net MarginNet income ÷ Revenue | +9.2% | +7.0% | -6.8% | +5.9% | +4.9% |
| FCF MarginFCF ÷ Revenue | +5.2% | +7.0% | +10.0% | +5.1% | +8.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.4% | -4.1% | -2.5% | +8.5% | -4.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.9% | +6.5% | +32.1% | +17.8% | -6.5% |
Valuation Metrics
TDOC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 6.4x trailing earnings, AVAH trades at a 70% valuation discount to CACI's 21.5x P/E. Adjusting for growth (PEG ratio), SAIC offers better value at 0.73x vs CACI's 1.78x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.4B | $3.5B | $1.3B | $10.6B | $4.2B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $4.7B | $1.6B | $13.9B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 6.42x | 11.66x | -6.36x | 21.55x | 12.20x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.61x | 7.72x | — | 17.07x | 9.31x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.14x | — | 1.78x | 0.73x |
| EV / EBITDAEnterprise value multiple | 8.90x | 6.49x | 15.65x | 14.44x | 6.42x |
| Price / SalesMarket cap ÷ Revenue | 0.58x | 0.65x | 0.52x | 1.23x | 0.58x |
| Price / BookPrice ÷ Book value/share | 7.45x | 2.22x | 0.92x | 2.77x | 2.91x |
| Price / FCFMarket cap ÷ FCF | 11.30x | 9.57x | 4.58x | 22.07x | 7.33x |
Profitability & Efficiency
AVAH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
AVAH delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-12 for TDOC. SAIC carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVAH's 6.91x. On the Piotroski fundamental quality scale (0–9), MMS scores 8/9 vs TDOC's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.5% | +21.8% | -12.4% | +13.1% | +23.7% |
| ROA (TTM)Return on assets | +12.4% | +8.8% | -5.9% | +5.7% | +6.8% |
| ROICReturn on invested capital | +15.1% | +15.1% | -11.5% | +9.2% | +14.2% |
| ROCEReturn on capital employed | +18.6% | +17.4% | -10.0% | +11.6% | +12.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 6.91x | 0.86x | 0.75x | 0.86x | 0.14x |
| Net DebtTotal debt minus cash | $1.2B | $1.2B | $259M | $3.2B | $35M |
| Cash & Equiv.Liquid assets | $193M | $260M | $781M | $106M | $182M |
| Total DebtShort + long-term debt | $1.3B | $1.4B | $1.0B | $3.3B | $217M |
| Interest CoverageEBIT ÷ Interest expense | 1.79x | 4.93x | -8.76x | 4.52x | 3.99x |
Total Returns (Dividends Reinvested)
AVAH leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CACI five years ago would be worth $18,233 today (with dividends reinvested), compared to $514 for TDOC. Over the past 12 months, AVAH leads with a +22.5% total return vs SAIC's -21.7%. The 3-year compound annual growth rate (CAGR) favors AVAH at 87.7% vs TDOC's -34.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.6% | -25.3% | +2.8% | -10.5% | -6.5% |
| 1-Year ReturnPast 12 months | +22.5% | -13.5% | +2.4% | +1.0% | -21.7% |
| 3-Year ReturnCumulative with dividends | +560.8% | -14.6% | -72.2% | +58.2% | -1.0% |
| 5-Year ReturnCumulative with dividends | -41.9% | -22.2% | -94.9% | +82.3% | +12.2% |
| 10-Year ReturnCumulative with dividends | -43.8% | +35.3% | -38.7% | +406.9% | +104.0% |
| CAGR (3Y)Annualised 3-year return | +87.7% | -5.1% | -34.7% | +16.5% | -0.3% |
Risk & Volatility
SAIC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SAIC is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than TDOC's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SAIC currently trades 75.7% from its 52-week high vs MMS's 64.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.29x | 0.63x | 1.89x | 0.29x | 0.27x |
| 52-Week HighHighest price in past year | $10.32 | $100.00 | $9.77 | $683.50 | $124.11 |
| 52-Week LowLowest price in past year | $3.73 | $60.75 | $4.40 | $409.62 | $81.08 |
| % of 52W HighCurrent price vs 52-week peak | +65.3% | +64.3% | +74.2% | +70.4% | +75.7% |
| RSI (14)Momentum oscillator 0–100 | 57.9 | 49.7 | 76.1 | 33.7 | 45.7 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 685K | 5.2M | 270K | 556K |
Analyst Outlook
MMS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AVAH as "Hold", MMS as "Buy", TDOC as "Hold", CACI as "Buy", SAIC as "Hold". Consensus price targets imply 71.2% upside for MMS (target: $110) vs 3.8% for SAIC (target: $98). For income investors, MMS offers the higher dividend yield at 1.85% vs SAIC's 1.60%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $11.00 | $110.00 | $7.58 | $725.50 | $97.50 |
| # AnalystsCovering analysts | 12 | 16 | 42 | 29 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +1.8% | — | — | +1.6% |
| Dividend StreakConsecutive years of raises | — | 2 | — | — | 2 |
| Dividend / ShareAnnual DPS | — | $1.19 | — | — | $1.51 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +12.8% | 0.0% | +1.6% | +10.5% |
AVAH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TDOC leads in 1 (Valuation Metrics).
AVAH vs MMS vs TDOC vs CACI vs SAIC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVAH or MMS or TDOC or CACI or SAIC a better buy right now?
For growth investors, Aveanna Healthcare Holdings Inc.
(AVAH) is the stronger pick with 20. 2% revenue growth year-over-year, versus -2. 9% for Science Applications International Corporation (SAIC). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 4x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Maximus, Inc. (MMS) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVAH or MMS or TDOC or CACI or SAIC?
On trailing P/E, Aveanna Healthcare Holdings Inc.
(AVAH) is the cheapest at 6. 4x versus CACI International Inc at 21. 5x. On forward P/E, Maximus, Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Science Applications International Corporation wins at 0. 56x versus CACI International Inc's 1. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — AVAH or MMS or TDOC or CACI or SAIC?
Over the past 5 years, CACI International Inc (CACI) delivered a total return of +82.
3%, compared to -94. 9% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: CACI returned +406. 9% versus AVAH's -43. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVAH or MMS or TDOC or CACI or SAIC?
By beta (market sensitivity over 5 years), Science Applications International Corporation (SAIC) is the lower-risk stock at 0.
27β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately 596% more volatile than SAIC relative to the S&P 500. On balance sheet safety, Science Applications International Corporation (SAIC) carries a lower debt/equity ratio of 14% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AVAH or MMS or TDOC or CACI or SAIC?
By revenue growth (latest reported year), Aveanna Healthcare Holdings Inc.
(AVAH) is pulling ahead at 20. 2% versus -2. 9% for Science Applications International Corporation (SAIC). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to 7. 4% for Science Applications International Corporation. Over a 3-year CAGR, CACI leads at 11. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVAH or MMS or TDOC or CACI or SAIC?
Aveanna Healthcare Holdings Inc.
(AVAH) is the more profitable company, earning 9. 2% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAH leads at 10. 9% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVAH or MMS or TDOC or CACI or SAIC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Science Applications International Corporation (SAIC) is the more undervalued stock at a PEG of 0. 56x versus CACI International Inc's 1. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Maximus, Inc. (MMS) trades at 7. 7x forward P/E versus 17. 1x for CACI International Inc — 9. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMS: 71. 2% to $110. 00.
08Which pays a better dividend — AVAH or MMS or TDOC or CACI or SAIC?
In this comparison, MMS (1.
8% yield), SAIC (1. 6% yield) pay a dividend. AVAH, TDOC, CACI do not pay a meaningful dividend and should not be held primarily for income.
09Is AVAH or MMS or TDOC or CACI or SAIC better for a retirement portfolio?
For long-horizon retirement investors, Science Applications International Corporation (SAIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
27), 1. 6% yield, +104. 0% 10Y return). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SAIC: +104. 0%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVAH and MMS and TDOC and CACI and SAIC?
These companies operate in different sectors (AVAH (Healthcare) and MMS (Industrials) and TDOC (Healthcare) and CACI (Technology) and SAIC (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AVAH is a small-cap high-growth stock; MMS is a small-cap deep-value stock; TDOC is a small-cap quality compounder stock; CACI is a mid-cap quality compounder stock; SAIC is a small-cap deep-value stock. MMS, SAIC pay a dividend while AVAH, TDOC, CACI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.